Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine and inflammation in haemodialysis patients with chronic kidney disease
ACTRN12617000922370Phase 2Recruiting
- Sponsor
- A/Prof Sanjay Patel
- Start
- Aug 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of colchicine in chronic kidney disease (CKD) (2 arms), sponsored by A/Prof Sanjay Patel. Primary endpoints: Monocyte function and Neutrophil function. Started Aug 2017; status: recruiting.
02
Drugs
colchicine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ACTRN12617000922370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000922370.